111 related articles for article (PubMed ID: 27245623)
1. Gastric Cancer Patients with High PLK1 Expression and DNA Aneuploidy Correlate with Poor Prognosis.
Otsu H; Iimori M; Ando K; Saeki H; Aishima S; Oda Y; Morita M; Matsuo K; Kitao H; Oki E; Maehara Y
Oncology; 2016; 91(1):31-40. PubMed ID: 27245623
[TBL] [Abstract][Full Text] [Related]
2. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
Jang YJ; Kim YS; Kim WH
Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of polo-like kinase 1 in human gastric cancer.
Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
[TBL] [Abstract][Full Text] [Related]
5. [Mitosis arrest caused by inhibition of PLK1 expression in gastric cancer MKN45 cells].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):164-8. PubMed ID: 16875597
[TBL] [Abstract][Full Text] [Related]
6. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.
Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Sharrocks AD; Ang YS
BMC Res Notes; 2015 Nov; 8():676. PubMed ID: 26576650
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.
Yamamoto Y; Matsuyama H; Kawauchi S; Matsumoto H; Nagao K; Ohmi C; Sakano S; Furuya T; Oga A; Naito K; Sasaki K
Oncology; 2006; 70(3):231-7. PubMed ID: 16837776
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.
Li Z; Liu J; Li J; Kong Y; Sandusky G; Rao X; Liu Y; Wan J; Liu X
J Biol Chem; 2017 Oct; 292(42):17461-17472. PubMed ID: 28900036
[TBL] [Abstract][Full Text] [Related]
10. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Cebrián A; Gómez Del Pulgar T; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Manzarbeitia F; García-Foncillas J
Pathol Res Pract; 2016 Dec; 212(12):1133-1137. PubMed ID: 27712975
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
[TBL] [Abstract][Full Text] [Related]
12. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
Spänkuch B; Heim S; Kurunci-Csacsko E; Lindenau C; Yuan J; Kaufmann M; Strebhardt K
Cancer Res; 2006 Jun; 66(11):5836-46. PubMed ID: 16740723
[TBL] [Abstract][Full Text] [Related]
15. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
Lassus H; Staff S; Leminen A; Isola J; Butzow R
Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
17. BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells.
Izumi H; Matsumoto Y; Ikeuchi T; Saya H; Kajii T; Matsuura S
Oncogene; 2009 Aug; 28(31):2806-20. PubMed ID: 19503101
[TBL] [Abstract][Full Text] [Related]
18. High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer.
Ando K; Kakeji Y; Kitao H; Iimori M; Zhao Y; Yoshida R; Oki E; Yoshinaga K; Matumoto T; Morita M; Sakaguchi Y; Maehara Y
Cancer Sci; 2010 Mar; 101(3):639-45. PubMed ID: 20132214
[TBL] [Abstract][Full Text] [Related]
19. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
Wang Z; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
[TBL] [Abstract][Full Text] [Related]
20. [Expression of checkpoint kinase 1 and polo-like kinase 1 and its clinicopathological significance in benign and malignant lesions of the stomach].
Yao H; Yang Z; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1080-4. PubMed ID: 21051833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
